Experts from across the toxicology field highlighted the latest research and testing methods shaping the future of the ...

BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced that findings from its dose range toxicity study for NES100, an innovative intranasal peptide for managing acute and chronic ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...

is pleased to announce its NES100 dose range finding toxicity study will be presented at The Society of Toxicology (SOT) 64 th annual meeting and Tox Expo taking place March 16-20 th in Orlando ...

The sot bap wave in LA doesn’t seem to be slowing down. Right on the heels of the arrival of South Korean pot rice chain DamSot, On6thAvenue, the hospitality group behind Origin Barbecue ...